Zimmer Biomet Announces Second Quarter 2022 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- S&P 500, Dow tick higher as investors weigh Mideast negotiations
- Oil falls 4% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Companies to add 40 million barrels of oil to US SPR after Iran war ends, energy secretary says
- China makes small dent in deflation battle as supply-demand imbalance persists
- Sanuwave cuts Q2 2026 revenue guidance amid Ultramist sales pressure
Zimmer Biomet Holdings (ZBH) Tops Q2 EPS by 18c; Bumps Guidance Slightly
August 2, 2022 6:32 AM EDTZimmer Biomet Holdings (NYSE: ZBH) reported Q2 EPS of $1.82, $0.18 better than the analyst estimate of $1.64. Revenue for the quarter came in at $1.78 billion versus the consensus estimate of $1.72 billion.
GUIDANCE:
Zimmer Biomet Holdings sees FY2022 EPS of $6.70-$6.90, versus... More
